Unlocking Hidden Health Insights to Improve Immuno-Oncology Care
Powering Personalized Medicine
Just as Immuno-Oncology treatments use the body’s own system to prevent, control, and eliminate cancer, IO-IQ AI uses personal physiological signature to continuously monitor each patient’s unique response for potential post-treatment side effects.
Streamlined Development
IO-IQ helps cell and gene therapy developers quickly attain more precise understanding of a therapy's efficacy and safety, leading to faster and more efficient development and strong support for regulatory approvals.
Safer Treatments With Better Patient Outcomes
IO-IQ is building a future where patients can benefit from state-of-the-art, life-saving Immuno-oncology therapies with a reduced risk and a home-based recovery following treatment.
The IO-IQ Mission
IO-IQ's mission is to make cell and gene therapy safer, more effective, less expensive, and accessible to all patients in need.
Who We Are
IO-IQ is a medical device technology company that uses continuous, remote patient data from wearable sensors and advanced digital biomarkers to monitor patient health.
Leadership
The IO-IQ team brings decades of experience in technology development, medical care, commercialization and health research.
Contact Us
To learn more about IO-IQ, please complete this short form.